OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-04-05-accounts

Company No: 06606603 Charity No: 1129387

The Sydney Driscoll Neuro-Science Foundation (Company Limited by Guarantee)

Financial Statements

For The Year Ended 5 April 2021

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMTED BY GUARANTEE)

CONTENTS

Page
Legal and Administrative Information 1
Trustees’ Annual Report 2
Independent Auditor’s Report to the Members 5
Statement of Financial Activities 8
Balance Sheet 9
Notes to the Financial Statements 10

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMTED BY GUARANTEE)

COMPANY INFORMATION

Registered Charity Name The Sydney Driscoll Neuro-Science Foundation Charity Registration Number 1129387 Company Registration Number 06606603 Trustees/Directors J A Ferguson N Gurusinghe J Winnard N D Park Registered Office 7 Winckley Square Preston PR1 3JD Secretary Mr John Andrew Ferguson Statutory Auditor MHA Moore and Smalley Chartered Accountants Richard House 9 Winckley Square Preston PR1 3HP Solicitors Napthens 7 Winckley Square Preston PR1 3JD

-1-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

TRUSTEES’ ANNUAL REPORT

FOR THE YEAR ENDED 5 APRIL 2021

The trustees, who are also directors for the purposes of company law are pleased to present their present their combined directors and trustees’ report and financial statements for the year ended 5 April 2021.

The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Memorandum and Articles of Association, and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (October 2019)

Structure, governance and management

Governing document

The charity is a company limited by guarantee, governed by its Memorandum and Articles of Association, and was incorporated on 30 May 2008.

Recruitment and appointment of trustees

Trustees are recruited from time to time by the existing trustees on the basis of their knowledge and experience of the administration and delivery of health services fund raising and where it is perceived that they are qualified to deliver other relevant experience and skills to the charity. The trustees are actively seeking to appoint additional suitable directors and trustees.

Trustees induction and training

Upon appointment the trustees are generally appraised in meetings of the financial position and the objects of the charity and of relevant ongoing programmes for delivery of these objects.

Organisational structure

The board of trustees administers the charity. The trustees who served during the period are set out on page 1. The trustees meet quarterly.

Risk management

The trustees have examined the major strategic, business and operational risks which the charity faces and confirm that systems have been established to enable regular reports to be produced so that the necessary steps can be taken to lessen the risks.

Objectives and activities

The charity's objects are to heal and relieve sick, disabled and aged persons from the disabilities and infirmities with which they are afflicted in one or more of the following ways:

The trustees confirm that they have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the charity’s aims and objectives and in planning future activities and setting the grant making policy for the year.

-2-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

TRUSTEES’ ANNUAL REPORT

FOR THE YEAR ENDED 5 APRIL 2021

Achievement and performance

The details of the charity’s income and expenditure for the year and its net assets at 5 April 2021 are on pages 8 and 9 of the financial statements. In summary, the charity generated income of £27,376 in the year to fund expenditure of £42,330.

During the accounting period the trustees have continued their sponsorship of the development and maintenance of a brain tissue bank at the Tissue Culture Laboratory at Royal Preston Hospital and sponsored the SDNF annual award for research papers in neuroscience related work, although the annual SDNF lecture did not proceed because of the Covid pandemic. They have continued the funding and development of the SDNF Neurosciences Library situated in the neuroscience department at Royal Preston Hospital. The trustees are engaged with The School of Clinical and Biomedical Sciences at The University of Central Lancashire in relation to the sponsorship of a new research project relating to neuro oncology. They have entered into an agreement with the University to contribute £100,000 over a period of three years to a jointly managed scheme for research into treatment of brain cancer. This project has been delayed because of Covid related issues which have affected The University of Central Lancashire personnel but is now proceeding and a series of research projects have been identified which will use the full contribution.

There are no restrictions on the charity’s power to invest. The investment strategy is reviewed regularly by the trustees and takes account of the demand for funds. Due to the volatility in the investment markets, the trustees were content to hold high levels of cash deposits at 5 April 2021. They are continuing to review this policy and to take advice from their investment advisers, Messrs J M Finn & Co. The trustees will not invest in companies associated with the tobacco industry.

Financial review

Reserves policy

At 5 April 2021 the charity held unrestricted reserves of £830,548. The trustees have the power to apply both capital and income towards the objects of the Foundation. The trustees’ current policy and practice is to spend the income and to make up any shortfall required to maintain their sponsorship of approved projects out of capital. They are prepared in appropriate circumstances to make significant grants out of capital towards suitable projects.

Principal funding sources

Principal funding sources are the historic endowment received under the will of Mrs Lucille Driscoll and income generated thereon. During the relevant accounting year the trustees have received significant additional grants from patients of Royal Preston Hospital and their families.

Going concern

The Trustees have considered the impact of the Government response to Covid-19 on the activity of the charity. The expenditure of the charity is variable with few fixed costs. Income is not expected to reduce significantly and projects are continuing where possible. As a result, the Trustees consider that the charity has sufficient reserves to meet liabilities as they fall due for a period of at least twelve months from the date of the signing of the accounts.

Plans for future periods

The trustees will continue to meet their objectives in the current year.

-3-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE) TRUSTEES, ANNUAL REPORT FOR THE YEAR ENDED S APRIL 2021 Responslbllltles of the trustees The Iruslees (who are also directors of th& ¢harlly for the purposes of cornpany18w) are respons6blg for preparlng the Trustees, Annual Report and the financial slalemenls in accordance with applicable law and Unit8d Kin*om Accounting Stsndards (United Kingdom Gene¥ally Accepted Accounting Pr8cti¢e}. Company law requires the Iruslees lo prepare flnancial slalamenls for aach financial year, which give a tru8 and fair view of the slate of affairs of the charitable company and ol the incoming resourcè$ and applic8tlon of resources, includlng the Ineomè and expenditure. of the charitable company for that peri(Kl. In preparing Ihese financial stalemenls, the trustees are required to= select suitable accounting policies and than apply Iham eonsist8nlly', observe the methods and principlgs in the Charities SORP 2019 IFRS102)', make judgements and eslim8tes that are reasonablè and prudènt., state whether applicable UK Accounting Standards hav8 been followed. subject lo any material departures disclosed and explained In the flnanclal statements., prepare the financial ytalemgnts on the golng concern basis unles5 11 is inappropriate lo presume that Ihg charitable Company wlll continue in opeTalion. The Iruslees are responsible for k8&ping ad8qu8t8 accounting records that disclose with reasonable accuracy al any time the financial position of the charitable ¢(mP8ny and enable them lo ensure that the linanolal statements comply with the Cornpani8s Act 2006. They are also responsible for safeguarding th8 assats of the charitabl8 eomp8ny and hance for taking reasonable steps for the prevention and dele¢lion of fraud and other irregularities. In so far as the trustees are aware.. there is no relevant audit infortnalion t)f whl¢h the charitable cornpany's auditor is unawarè., 8rtd the Iruslees have taken all steps Ihal they ought lo have laken to make themselves awaré ol any rèlevant 8udil infomiation 8nd to èstablish that the audilor is aware of that information. Audltors A ¥esolution to re-appoint MHA Moore and Smalley as audltors forlhe ensuing year will be proposed al Ihe annual general meetlng In accordance with the Charllies Act 2011. Signed by order of the trust88s Mr John Andrew Ferguson Company Secretary Reglslored office.. 7 Wlnckley Square P￿StOn Lancashire PR13JD 2710112021 Oate..

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS FOR THE YEAR ENDED 5 APRIL 2021

Opinion

We have audited the financial statements of The Sydney Driscoll Neuro-Science Foundation (the ‘charitable company’) for the year ended 5 April 2021, which comprise the Statement of Financial Activities, the Balance Sheet and the related notes, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information included in the trustees annual report. The other information comprises the information included in the trustees’ annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

-5-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS FOR THE YEAR ENDED 5 APRIL 2021

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 3 and 4, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

-6-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS

FOR THE YEAR ENDED 5 APRIL 2021

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the charitable company’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

………………………….

Nicola Mason (Senior Statutory Auditor) For and on behalf of MHA Moore and Smalley Chartered Accountants & Statutory Auditor

Richard House Winckley Square Preston PR1 3HP 04/02/2022 Date: ………………………..

-7-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING THE INCOME & EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 5 APRIL 2021

Note
Income from:
Donations and legacies
Investment income
Other income
Total incoming resources
3
Expenditure on:
Raising funds
Charitable activities
Total resources expended
4
Net income/(expenditure) before investments
Net gains / (losses) on investments
Net income/(expenditure)
Reconciliation of funds
Balance brought forward at 6 April 2020
Balance carried forward at 5 April 2021
Total funds
for the year
ended
5 April
2021
£
829
26,541
6
27,376
5,417
36,913
42,330
(14,954)
147,155
132,201
698,347
830,548
Total funds
for the year
ended
5 April
2020
£
5,082
28,928
18
34,028
5,940
47,205
53,145
(19,117)
(183,767)
(202,884)
901,231
698,347

All movements in both the current and prior year are in unrestricted funds and relate to continuing activities.

-8-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE BALANCE SHEET AS AT S APRIL 2021 2021 2020 Note Fixed assets Investmènts 770,988 623,790 Current assèts Debtors Cash al bank 4.265 59.212 4,467 74.411 63,477 78,878 Current Ilabllltlgs Credilors.. amounts lalling due within one year 13,9171 14,3211 Net current assets 59,560 74,557 Net assets 830,548 698,347 The fund$ of th? charlty: Unrestricted 830.548 698.347 Total charlty funds 830.548 698.347 These financial slalemenls were approved and authorised for issue by the Iruslees on slgned n their behalf by.. 27101121 -and ar J A Ferguson Trustee Company Reglslrallon Number.. 06606603 Thè notes on pages 10 to 14 form part of these fflnanclal slalements.

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2021

1 Accounting policies

Legal form

The charity constitutes a limited company, limited by guarantee as defined by the Companies Act 2006, incorporated in England and Wales. The registered office is as stated on page 1. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. The nature of the charity’s operations and principal activities are in the detailed in the Report of the Trustees.

Basis of accounting

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Accounting Practice. The charity has applied Update Bulletin 1 as published on 2 February 2016 and does not include a cash flow statement on the grounds that it is applying FRS 102 Section 1A.

The Sydney Driscoll Neuro-Science Foundation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.

Preparation of the accounts on a going concern basis

The financial statements have been prepared on a going concern basis and the trustees believe that no material uncertainties exist. The Trustees have considered the impact of the Government response to Covid-19 on the activity of the charity. The expenditure of the charity is variable with few fixed costs. Income is not expected to reduce significantly and projects are continuing where possible. As a result, the Trustees consider that the charity has sufficient reserves to meet liabilities as they fall due for a period of at least twelve months from the date of the signing of the accounts.

Income

Income is recognised in the Statement of Financial Activities on an accruals basis. Investment income is recognised on an accruals basis.

Resources expended

Expenditure, inclusive of VAT, is charged to the Statement of Financial Activities on an accruals basis.

Financial instruments

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Investments

Investments are stated on the balance sheet at market value. Unrealised gains and losses, and gains and losses on disposal are recorded in the Statement of Financial Activities.

Cash at bank and in hand

Cash at bank includes cash held by the administrator, investment manager and banks.

Accruals

Accruals are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. These are normally recognised at their settlement amount.

-10-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 5 APRIL 2021

1 Accounting policies (continued)

Books

Expenditure on books and periodicals is written off in the accounting period in which this is incurred.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each funds is included in the notes to the financial statements.

2 Judgements and key sources of estimation uncertainty

There have been no significant judgements (apart from those involving estimates) made in the process of preparing the accounts. There have been no key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

3 Incoming resources

Incoming resources
Year ended Year ended
5 April
5 April
2021 2020
£ £
Donations and legacies
Donations 829 5,082
Investment income
M & G Investments Charifund 12,462 16,133
CCLA Investments COIF 43 305
Blackrock Asset Management Charinco 11,513 9,044
Glaxosmithkline Ordinary shares 1,880 1,880
BP Ordinary shares 201 324
BMO Commercial Property Trust 442 1,242
26,541 28,928
Other income
Bank interest 6 18
27,376 34,028

-11-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2021

4 Resources expended

Charitable activities
Direct costs
Project funding
Library services
Lecture fees and expenses
Support costs
Insurance
Accounting and administration fees
Web hosting
Bank charges
Sundry expenses
Admin Fee
Governance - Auditor’s remuneration (inclusive of VAT)
Total charitable activities
Cost of raising funds
Investment management charges
Year ended
5 April
2021
£
19,100
-
4,603
23,703
1,046
4,590
-
52
634
5,000
1,888
13,210
36,913
5,417
42,330
Year ended
5 April
2020
£
23,222
6,105
10,165
Year ended
5 April
2020
£
23,222
6,105
10,165
39,492
1,000
4,657
-
95
197
-
1,764
7,713
47,205
5,940
53,145

Project funding comprises: £19,100 Lancashire Teaching Hospitals (institution).

2021 2020
£ £
Auditor’s remunerations consists of the following charges:
- Audit of the financial statements (exclusive of VAT) 1,544 1,470

-12-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2021

5 Investments

M & G Investments
Charifund
Blackrock Asset
Management
Charinco
CCLA investments
COIF Charities
BMO Commercial
Property Trust
Glaxosmithkline
Ordinary Shares
BP Ordinary Share
Market
value at
6 April
2020
£
221,763
296,205
51,647
15,801
35,001
3,373
623,790
Additions
£
-
-
-
-
-
-
-
Sales
proceeds
£
-
-
-
-
-
-
-
Change in
value
£
62,636
89,373
-
598
(4,977)
(475)
147,156
Market
value at
5 April
2021
£
284,399
385,578
51,690
16,399
30,024
2,898
770,988
Cost at
5 April
2021
£
188,249
168,910
13,000
23,000
31,439
6,202
430,800

The aggregate amount of listed investments at 5 April 2021 was £32,922 (2020: £38,374). The aggregate amount of cash and cash equivalents at 5 April 2021 was £51,690 (2020: £51,647).

6 Debtors

Debtors
Year ended Year ended
5 April
5 April
2021 2020
£ £
Prepayments and accrued income 4,265 4,467
Creditors: amounts falling due within one year
Year ended Year ended
5 April
5 April
2021 2020
£ £
Accruals 3,917 4,321

7 Creditors: amounts falling due within one year

-13-

THE SYDNEY DRISCOLL NEURO-SCIENCE FOUNDATION (COMPANY LIMITED BY GUARANTEE)

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 5 APRIL 2021

8 Trustees’ remuneration, trustees’ expenses and remuneration paid to key management personnel

None of the trustees received any remuneration or expenses during the current or previous year.

The charity had no paid key management personnel during the current or previous year.

9 Financial commitments

Approximately eight years ago the Foundation agreed on an informal basis to contribute approximately £12,400 to fund work at Royal Preston Hospital to extend and refurbish the neuroscience library. This work has been carried out by the Lancashire Teaching Hospital Trust which has not followed up the matter of this contribution and it is now considered unlikely that it will do so.

The Foundation entered into an agreement in 2019 with the University of Central Lancashire to contribute £100,000 over a period of three years to a jointly managed scheme for research into treatment of brain cancer. This project has been delayed because of Covid related issues which have affected The University of Central Lancashire personnel but is now proceeding and a series of research projects have been identified which will use the full contribution.

10 Taxation

The Foundation is a registered charity and consequently there is no liability to taxation on income derived from its charitable activities.

11 Financial instruments

Financial instruments
2021 2020
£ £
Carrying amount of financial assets
Measured at fair value through net income/expenditure 770,988 623,790

-14-